文献速递妇科

终生排卵年数与上皮性卵巢癌风险及生存的系统综述与Meta分析

Lifetime ovulations and epithelial ovarian cancer risk and survival: A systematic review and meta-analysis.
PubMed 文献 · Gynecol Oncol · 2022-04-23

该系统综述纳入31篇报告(其中24项研究进入Meta分析),评估终生排卵年数(LOY)与上皮性卵巢癌(EOC)风险及生存的关系。LOY最高组女性EOC风险约为最低组的2.26倍(95%CI 1.94-2.83),且与浆液性和子宫内膜样肿瘤风险相关,与黏液性肿瘤无显著关联。仅4项研究探讨LOY与生存,无法定量评估,其中3项报告LOY越高结局越差。

要点

  • LOY最高组EOC风险约为最低组的2.26倍(95%CI 1.94-2.83)。
  • LOY与浆液性(合并OR 2.31)和子宫内膜样(合并OR 3.05)肿瘤风险相关。
  • LOY与黏液性肿瘤无显著关联(合并OR 1.52,95%CI 0.87-2.64)。

核心结论

  • LOY是特定EOC组织学类型的危险因素,并可能影响EOC生存。
  • LOY的标准定义、个体水平数据和更大样本量将有助于更精确地量化LOY与EOC的关联,从而为EOC风险评估模型提供依据。

研究设计与样本

  • 按照PRISMA指南进行的系统综述,检索PubMed、MEDLINE和Embase至2021年12月31日。
  • 共31篇报告纳入LOY与EOC风险的定性综述,其中24项研究数据充分进入Meta分析。
  • 仅4项研究探讨LOY与生存的关联,无法进行定量评估。

主要发现

  • LOY最高组女性EOC风险约为最低组的2.26倍(95%CI 1.94-2.83)。
  • LOY与浆液性肿瘤风险相关(合并OR 2.31,95%CI 1.60-3.33)。
  • LOY与子宫内膜样肿瘤风险相关(合并OR 3.05,95%CI 2.08-4.45)。
  • LOY与黏液性肿瘤无显著关联(合并OR 1.52,95%CI 0.87-2.64)。
  • 4项生存研究中3项报告LOY越高结局越差。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 仅4项研究探讨LOY与生存的关联,无法进行定量评估。
  • LOY与黏液性肿瘤的合并OR 95%CI跨1,未达统计学显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the relationship between lifetime ovulatory years (LOY) and Epithelial ovarian cancer (EOC) risk and survival. METHODS: A systematic review was performed in accordance with PRISMA guidelines. Relevant studies were identified from PubMed, MEDLINE, and Embase through December 31, 2021 combining the following search: [("ovulation" or "ovulation cycles" or "ovulatory age" or "ovulatory cycles") and ("ovarian cancer" or "ovarian neoplasms") and ("humans" and "female")]. Reference lists of identified articles were searched for additional studies. Studies were excluded from consideration if they were not a published, peer-review article; not in English; lacked data on effect sizes; had data included in another publication; or were a review article, cross-sectional study, or case report. Two independent investigators screened abstracts and full texts for eligibility, extracted study-level data, and assigned study quality. Disagreements between abstractors were discussed and resolved by consensus. RESULTS: Thirty-one reports were included in the qualitative review of LOY and EOC risk, inclusive of 24 studies with sufficient data to be included in the meta-analysis. Women with the highest level of LOY had 2.26 times higher odds of EOC than women with the lowest level of LOY (95% CI 1.94-2.83). LOY was associated with risk of serous (pooled OR 2.31, 95% CI 1.60-3.33) and endometrioid tumors (pooled OR 3.05, 95% CI 2.08-4.45) but not mucinous disease (pooled OR 1.52, 95% CI 0.87-2.64). There were only four studies examining the LOY-survival association, which precluded a quantitative assessment; however, three of the published studies reported worse outcome with greater LOY. CONCLUSION: LOY is a risk factor for specific EOC histotypes and may also influences EOC survival. Standard definitions of LOY, participant-level data, and larger sample size will enable more precise quantitation of the LOY-EOC association, which can inform EOC risk assessment models.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Fu Z, Taylor S, Modugno F, et al. Lifetime ovulations and epithelial ovarian cancer risk and survival: A systematic review and meta-analysis. Gynecol Oncol. 2022. PMID: 35473671. doi:10.1016/j.ygyno.2022.04.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。